1. Home
  2. VSCO vs ICUI Comparison

VSCO vs ICUI Comparison

Compare VSCO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VSCO

Victorias Secret & Co.

HOLD

Current Price

$60.36

Market Cap

4.3B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$150.86

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSCO
ICUI
Founded
1977
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.6B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
VSCO
ICUI
Price
$60.36
$150.86
Analyst Decision
Buy
Buy
Analyst Count
11
5
Target Price
$49.70
$179.50
AVG Volume (30 Days)
2.0M
243.3K
Earning Date
03-04-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
6.59
N/A
EPS
2.08
N/A
Revenue
$6,390,000,000.00
$2,320,363,000.00
Revenue This Year
$7.43
N/A
Revenue Next Year
$3.84
N/A
P/E Ratio
$29.25
N/A
Revenue Growth
2.95
N/A
52 Week Low
$13.76
$107.00
52 Week High
$66.89
$165.17

Technical Indicators

Market Signals
Indicator
VSCO
ICUI
Relative Strength Index (RSI) 56.64 52.34
Support Level $53.27 $149.03
Resistance Level $62.37 $155.60
Average True Range (ATR) 3.18 4.84
MACD -0.64 -0.58
Stochastic Oscillator 55.94 31.77

Price Performance

Historical Comparison
VSCO
ICUI

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: